Though relatively rare and likely under-diagnosed, the BCR-JAK2 fusion event in this case with CML/MPD adds to the spectrum of rare yet recurrent translocation partners for each of the genes, respectively. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.